← Evidence map

ArticleDrug safety2021

Safety Consequences of Off-Label Drugs Used for COVID-19.

Nabarun DasguptaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2021
2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33666902